Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women

Objective: To investigate the efficacy, safety, and dose response of three doses of ibandronate, given intermittently by intravenous (IV) injection every three months, in preventing postmenopausal osteoporosis. Patients and methods: 629 postmenopausal women, categorised according to time since menop...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Stakkestad, J, Benevolenskaya, L, Stepan, J, Skag, A, Nordby, A, Oefjord, E, Burdeska, A, Jonkanski, I, Mahoney, P
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2003
Soggetti:
Extended Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1754320/
https://ncbi.nlm.nih.gov/pubmed/12972476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.62.10.969
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi